Workers whose employers fall outside the roughly one in five plans offering coverage face the same problem through a different door
Shed started a research protocol about six weeks earlier
People Going Blind From GLP-1: Risks, Evidence and Protection Recent reports have raised concerns about potential links between GLP-1 medications and vision problems, prompting questions about whether people are going blind from GLP-1 treatments
#NEJM #GLP1 #Obesity #Diabetes #Endocrinology #MedicalAffairs #HealthcareLeadership #HealthSystems #LATAM #Pharmacovigilance #AccessToCare To view or add a comment, sign in 5,791 followers
However, the predominant background treatment was metformin, used either as monotherapy or in combination with other medications
Accurate address data is required for mail notifications and jurisdictional handling (e.g., Quebec routing)